These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24102962)

  • 1. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.
    Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT
    Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation.
    Piché M; Watanabe N; Sakata M; Oda K; Toyohara J; Ishii K; Ishiwata K; Hotta H
    Neurosci Res; 2014; 81-82():78-84. PubMed ID: 24583336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.
    Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE
    Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
    Hagelberg N; Aalto S; Tuominen L; Pesonen U; Någren K; Hietala J; Scheinin H; Pertovaara A; Martikainen IK
    Neurosci Lett; 2012 Jul; 521(1):11-4. PubMed ID: 22622175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic disparities in pain processing among healthy adults: μ-opioid receptor binding potential as a putative mechanism.
    Letzen JE; Mun CJ; Kuwabara H; Burton EF; Boring BL; Walls T; Speed TJ; Wong DF; Campbell CM
    Pain; 2020 Apr; 161(4):810-820. PubMed ID: 31764386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil.
    Sprenger C; Eichler IC; Eichler L; Zöllner C; Büchel C
    J Neurosci; 2018 Mar; 38(10):2454-2470. PubMed ID: 29440535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
    Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
    Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable Roles of Cerebral μ-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET-fMRI Study.
    Karjalainen T; Karlsson HK; Lahnakoski JM; Glerean E; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Cereb Cortex; 2017 Aug; 27(8):4257-4266. PubMed ID: 28541428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys.
    Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL
    J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects.
    Wand GS; Weerts EM; Kuwabara H; Frost JJ; Xu X; McCaul ME
    Psychoneuroendocrinology; 2011 Nov; 36(10):1453-9. PubMed ID: 21549509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs).
    Harris RE; Zubieta JK; Scott DJ; Napadow V; Gracely RH; Clauw DJ
    Neuroimage; 2009 Sep; 47(3):1077-85. PubMed ID: 19501658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.